Abstract P455: Time to Blood Pressure Control and Association With Outcomes in Intracerebral Hemorrhage

Abstract only Background: Urgent blood pressure (BP) control is a mainstay of acute intracerebral hemorrhage (ICH) treatment, but the relationship between time to BP control and clinical outcomes is unclear. Methods: We performed a single-center observational cohort study on consecutive patients wit...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 52; no. Suppl_1
Main Authors Chuck, Carlin, Kalagara, Roshini, Abrantes, Tatiana, Doelfel, Savannah, Lin, Nelson F, Zhou, Helen, Dandapani, Hari, Kim, Daniel, Madsen, Tracy, Stretz, Christoph, Mahta, Ali, Wendell, Linda C, Thompson, Bradford B, Furie, Karen L, Reznik, Michael
Format Journal Article
LanguageEnglish
Published 01.03.2021
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract only Background: Urgent blood pressure (BP) control is a mainstay of acute intracerebral hemorrhage (ICH) treatment, but the relationship between time to BP control and clinical outcomes is unclear. Methods: We performed a single-center observational cohort study on consecutive patients with ICH who were hypertensive on hospital arrival over a 2-year period. We defined time-to-BP-control as the time from initial hospital arrival to first BP recorded below our institutionally mandated goal (systolic BP [SBP] <160 mmHg). Using multivariable logistic regression models adjusted for established clinical predictors and time from last-known-well to hospital arrival, we determined associations between time-to-BP-control, hematoma expansion (HE), and unfavorable 3-month outcome (modified Rankin Scale 4-6). We performed additional subgroup analyses in patients with arrival SBP >200 mmHg, hypertensive ICH etiology, and anticoagulation-related ICH. Results: Among 330 patients in our cohort, mean arrival SBP was 191±131 mmHg and mean time-to-BP-control was 2.3±1.5 hours. On univariate analysis, patients without HE had longer time-to-BP-control than those with HE (mean 2.5 vs. 2.1 hours, p=0.02). This was confirmed in multivariable models, where longer time-to-BP-control was associated with a lower likelihood of HE (OR 0.81 per hour, 95% CI 0.66-0.98), and was not associated with 3-month outcome (OR 0.99 per hour, 95% CI 0.81-1.21). Results were similar in subgroup analyses of patients with arrival SBP >200 mmHg and hypertensive ICH etiology. However, in those with anticoagulation-related ICH, longer time-to-BP-control was associated with a higher likelihood of unfavorable 3-month outcome (OR 2.02 per hour, 95% CI 1.13-3.61). Conclusion: Earlier BP control may not improve outcomes in all ICH patients, though some subgroups, such as those with anticoagulation-related ICH, may derive greater benefit from earlier treatment.
ISSN:0039-2499
1524-4628
DOI:10.1161/str.52.suppl_1.P455